Systemic antibiotherapy in patients admitted with an acute exacerbation of COPD. Association with mortality and readmissions. Experience from the pilot study in six regions of the Nacional Clinical Audit on COPD exacerbation in Spain (AUDIPOC)
G. López-Arranz, C. J. Alvarez, C. Esteban Gonzalez, J. Fernández Francés, R. Agüero, J. Hueto, M. Barrón, J. A. Riesco Miranda, C. Hernandez, F. Pozo (Madrid, , Santander, Navarra, Logroño, Cáceres, Barcelona, Spain)
Source: Annual Congress 2010 - Pharmacological treatment in primary care
Session: Pharmacological treatment in primary care
Session type: Thematic Poster Session
Number: 858
Disease area: Airway diseases, Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. López-Arranz, C. J. Alvarez, C. Esteban Gonzalez, J. Fernández Francés, R. Agüero, J. Hueto, M. Barrón, J. A. Riesco Miranda, C. Hernandez, F. Pozo (Madrid, , Santander, Navarra, Logroño, Cáceres, Barcelona, Spain). Systemic antibiotherapy in patients admitted with an acute exacerbation of COPD. Association with mortality and readmissions. Experience from the pilot study in six regions of the Nacional Clinical Audit on COPD exacerbation in Spain (AUDIPOC). Eur Respir J 2010; 36: Suppl. 54, 858
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: